J, W., B, P., T, L., & T, W. (2026). Glioma-derived extracellular vesicles as drivers of immunotherapeutic resistance: Mechanisms of immune reprogramming and metabolic intervention. Frontiers in immunology, 17, 1859282. https://doi.org/10.3389/fimmu.2026.1859282
Chicago Style (17th ed.) CitationJ, Wang, Peng B, Li T, and Wang T. "Glioma-derived Extracellular Vesicles as Drivers of Immunotherapeutic Resistance: Mechanisms of Immune Reprogramming and Metabolic Intervention." Frontiers in Immunology 17 (2026): 1859282. https://doi.org/10.3389/fimmu.2026.1859282.
MLA (9th ed.) CitationJ, Wang, et al. "Glioma-derived Extracellular Vesicles as Drivers of Immunotherapeutic Resistance: Mechanisms of Immune Reprogramming and Metabolic Intervention." Frontiers in Immunology, vol. 17, 2026, p. 1859282, https://doi.org/10.3389/fimmu.2026.1859282.